Palisade Capital Management LP Acquires 12,807 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Palisade Capital Management LP boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 2.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 613,332 shares of the company's stock after purchasing an additional 12,807 shares during the quarter. Palisade Capital Management LP owned about 0.67% of Acadia Healthcare worth $18,596,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ACHC. Teacher Retirement System of Texas acquired a new position in shares of Acadia Healthcare in the first quarter valued at $412,000. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Acadia Healthcare in the 1st quarter valued at approximately $222,000. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after acquiring an additional 3,428 shares during the period. UMB Bank n.a. raised its holdings in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares during the period. Finally, Congress Asset Management Co. raised its holdings in Acadia Healthcare by 24.7% during the 1st quarter. Congress Asset Management Co. now owns 173,517 shares of the company's stock worth $5,261,000 after buying an additional 34,328 shares during the period.

Wall Street Analyst Weigh In

ACHC has been the subject of several analyst reports. KeyCorp decreased their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Mizuho dropped their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 14th. Stephens raised Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Finally, Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Price Performance

NASDAQ ACHC traded up $0.71 during trading on Friday, hitting $23.90. 1,483,833 shares of the company's stock were exchanged, compared to its average volume of 1,845,444. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The company has a market cap of $2.20 billion, a PE ratio of 11.77, a P/E/G ratio of 4.44 and a beta of 0.93. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The stock's 50 day moving average price is $23.01 and its two-hundred day moving average price is $31.11.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The business's quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.84 earnings per share. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.